Portland, OR, Dec. 05, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Autologous Cell Therapy Market generated $4.3 billion in 2021, and is estimated to reach $29.1 billion by 2031, witnessing a CAGR of 21.0% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.
Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/11899
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $4.3 Billion |
| Market Size in 2031 | $29.1 Billion |
| CAGR | 21.0% |
| No. of Pages in Report | 188 |
| Segments Covered | Therapeutic Area, End User, and Region |
| Drivers | Rise in prevalence of cancer |
| Increase in the number of clinical trials | |
| Rise in public and private investments for the development of CAR (chimeric antigen receptor)-T therapy | |
| Opportunities | Rise in technological advancements and R&D in autologous cell therapy |
| Restraints | Inflated cost associated with autologous cell therapy and lower treatment facilities |
Covid-19 Scenario:
- The outbreak of the COVID-19 pandemic disrupted workflows in the healthcare sector worldwide. The reduced demand for autologous cell therapy, less supply of raw materials, and reduced manufacturing of products impacted the market negatively.
- The significant reduction in clinical trials for autologous cell therapy, owing to strict government guidelines against COVID-19, hampered the market growth. Moreover, reduced hospitals visits, closure of borders, and confinement of people to their homes impacted the supply chains of the life-saving medical products in the autologous cell therapy market.
- With the introduction of COVID-19 vaccines, the market has stabilized due to rise in patient visits to hospital and cancer treatment facilities. Cancer treatment is given priority which lead to an increase in demand for autologous cell therapy.
- The report offers a detailed segmentation of the global autologous cell therapy market based on therapeutic area, end user, and region. The report provides an analysis of each segment and sub-segment with the help of tables and figures. This analysis helps market players, investors, and new entrants in determining the sub-segments to be tapped on to achieve growth in the coming years.
Based on therapeutic area, the cancer segment held the largest share in 2021, accounting for nearly four-fifths of the global autologous cell therapy market share, and would maintain its dominance during the forecast period. Moreover, the same segment is estimated to witness the fastest CAGR of 21.2% during the forecast period.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/11899
Based on end user, the hospitals segment held the largest share in 2021, accounting for nearly three-fifths of the global autologous cell therapy market, and would lead the trail during the forecast period. However, the cancer treatment centers segment is estimated to witness the fastest CAGR of 21.6% during the forecast period.
Based on region, the market in North America was the largest in 2021, accounting for nearly three-fifths of the global autologous cell therapy market share, and is likely to maintain its leadership status during the forecast period. The market in Asia-Pacific, however, is expected to manifest the highest CAGR of 22.3% from 2022 to 2031. The other regions analyzed in the study include Europe and LAMEA.
Leading players of the global autologous cell therapy market analyzed in the research include Bristol Myers Squibb, Novartis AG, Vericel Corporation, Gilead Sciences (Kite Pharma, Inc.), Johnson & Johnson (Janssen Biotech, Inc.), Tego Science, Sanpower Group (Dendreon Pharmaceuticals LLC.), Holostem Terapie Avanzate S.r.l., GC Biopharma (GC Cell), and CORESTEM, Inc.
The report analyzes these key players of the global autologous cell therapy market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Ostomy Care and Accessories Market by Product (Ostomy Bags, Ostomy Accessories), by Application (Colostomy, Ileostomy, Urostomy), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2020-2030
Gene Editing Market By Technology (Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector-based Nucleases (TALENs), CRISPR-Cas9 Gene Editing, Restriction Enzymes, Others), By Application (Gene editing, Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Drug development, Others), By End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2021-2031
Blockchain Technology in Healthcare Market By Type (Public, Private), By Application (Supply Chain Management, Data Exchange and Interoperability, Claims Adjudication and Billing, Others), By End User (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers): Global Opportunity Analysis and Industry Forecast, 2021-2030
Opioids Market by Product Type (Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Others), by Application (Pain Management, Cough Treatment, Diarrhea Treatment): Global Opportunity Analysis and Industry Forecast, 2020-2030
Digital Therapeutics Market by Product (Software and Devices), Sales Channel (Business-to-Business and Business-to-Consumers), Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS), Disease Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID) and Others: Global Opportunity Analysis and Industry Forecast, 2022-2031
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com
